This episode takes up the practical mechanics of molecular testing in community oncology, beginning with turnaround time.
Ryan Haumschild, PharmD, MS, MBA, CPEL
Advertisement
Articles by Ryan Haumschild, PharmD, MS, MBA, CPEL
This episode opens with a distinction that matters more in lung cancer than many oncologists expect.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Ropeginterferon Alfa for Essential Thrombocytopenia
2
ASCO Issues First Living Guideline for Recurrent Ovarian Cancer Treatment
3
Botensilimab/Balstilimab Elicits Major Pathologic Responses in Colon Cancer
4
ADI-212 Receives FDA IND Clearance for Castration-Resistant Prostate Cancer
5